As of 2025-09-16, the Relative Valuation of Vanda Pharmaceuticals Inc (VNDA) is (11.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.38 USD, the upside of Vanda Pharmaceuticals Inc based on Relative Valuation is -362.5%.
The range of the Relative Valuation is (13.80) - (10.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.8x - 9.5x | 6.8x |
| Forward P/E multiples | 12.2x - 20.0x | 13.5x |
| Fair Price | (13.80) - (10.78) | (11.50) |
| Upside | -415.0% - -346.2% | -362.5% |
| Date | P/E |
| 2025-09-15 | -3.87 |
| 2025-09-12 | -3.98 |
| 2025-09-11 | -4.06 |
| 2025-09-10 | -3.95 |
| 2025-09-09 | -3.98 |
| 2025-09-08 | -4.02 |
| 2025-09-05 | -4.07 |
| 2025-09-04 | -4.10 |
| 2025-09-03 | -4.17 |
| 2025-09-02 | -4.16 |
| 2025-08-29 | -4.18 |
| 2025-08-28 | -4.15 |
| 2025-08-27 | -4.08 |
| 2025-08-26 | -4.12 |
| 2025-08-25 | -4.07 |
| 2025-08-22 | -4.19 |
| 2025-08-21 | -3.98 |
| 2025-08-20 | -4.06 |
| 2025-08-19 | -4.00 |
| 2025-08-18 | -4.03 |
| 2025-08-15 | -3.85 |
| 2025-08-14 | -3.91 |
| 2025-08-13 | -3.85 |
| 2025-08-12 | -3.80 |
| 2025-08-11 | -3.70 |
| 2025-08-08 | -3.71 |
| 2025-08-07 | -3.71 |
| 2025-08-06 | -3.73 |
| 2025-08-05 | -3.72 |
| 2025-08-04 | -3.76 |
| 2025-08-01 | -3.70 |
| 2025-07-31 | -3.76 |
| 2025-07-30 | -4.12 |
| 2025-07-29 | -4.13 |
| 2025-07-28 | -4.15 |
| 2025-07-25 | -4.18 |
| 2025-07-24 | -4.23 |
| 2025-07-23 | -4.27 |
| 2025-07-22 | -4.16 |
| 2025-07-21 | -4.11 |
| 2025-07-18 | -4.22 |
| 2025-07-17 | -4.29 |
| 2025-07-16 | -4.25 |
| 2025-07-15 | -4.20 |
| 2025-07-14 | -4.39 |
| 2025-07-11 | -4.18 |
| 2025-07-10 | -4.41 |
| 2025-07-09 | -4.43 |
| 2025-07-08 | -4.29 |
| 2025-07-07 | -4.32 |